4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-011525
CHIEF MEDICAL OFFICER sold 29,000 shares at an average $19.14 ($555,160)
- CHIEF MEDICAL OFFICER acquired 29,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-07-25 | Option exercise | +29,000 | $1.86 | $53,940 | 70,910 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-07-25 | Sale | −5,200 | $18.01 | $93,652 | 65,710 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-07-25 | Sale | −16,168 | $19.25 | $311,234 | 49,542 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-07-25 | Sale | −7,632 | $19.69 | $150,274 | 41,910 | D |
| Derivatives | |||||||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-07-25 | Option exercise · Share Option | −29,000 | 140,217 | D | ||
| Open-market sales · 29,000 sh · avg $19.14 · $555,160 | |||||||
Loading xslF345X05/form4-07272023_080730.xml…